The Evolving Landscape of Private Equity in Ophthalmology

Over the past decade, the consolidation of medicine by business entities has become increasingly commonplace, writes Dr. Robert Weinstock for CRSToday. Hospital-based systems and insurance companies have rapidly absorbed primary care specialties and other hospital-based subspecialties. In recent years, many outpatient surgical subspecialties with physician-owned ambulatory surgery centers and privately owned practices have partnered with or sold to private sector companies backed by private equity funding. In ophthalmology, there has been a similar escalating process with rapid consolidation, but a relatively small number of practices have chosen to go in this direction with regard to PE.

“I recently went through the process in our practice and have watched colleagues and friends evaluate it as well,” Weinstock writes. “It is increasingly obvious how complicated and challenging it is to navigate the intricacies of these large corporations and ultimately make such a profound decision.” Read more.

Total
0
Shares
Related Posts
Read More

A Changing Landscape for M&A in Healthcare

After a slow start to 2022, revenue from healthcare M&A activity in the second quarter of 2022 hit a record high of $19.2 billion. KPMG reports that technology plays a major role in these deals and states that many are “focused on acquiring digital capabilities, such as digital care and cloud-based platforms.”